Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: Data on 860 patients from the real-world multicenter observational project

2018 ◽  
Vol 272 ◽  
pp. 130-136 ◽  
Author(s):  
Maurizio Landolina ◽  
Giuseppe Arena ◽  
Saverio Iacopino ◽  
Roberto Verlato ◽  
Paolo Pieragnoli ◽  
...  
2017 ◽  
Vol 49 (1) ◽  
pp. 93-100 ◽  
Author(s):  
Ken Takarada ◽  
Ingrid Overeinder ◽  
Carlo de Asmundis ◽  
Erwin Stroker ◽  
Giacomo Mugnai ◽  
...  

Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Xue Zhao ◽  
Jianqiang Hu ◽  
Yan Huang ◽  
Yawei Xu ◽  
Yanzhou Zhang ◽  
...  

Objectives: The aim of this study was to determine the mechanisms and effectiveness of pulmonary antrum radial-linear (PAR) ablation in comparison with pulmonary vein isolation (PVI) in patients with paroxysmal atrial fibrillation (AF) after a long-term follow-up. Background: The one-year follow up data suggested that PAR ablation appeared to have a better outcome over the conventional PVI for paroxysmal AF. Methods: The enrollment occurred between March, 2011, and August, 2011, with the last follow-up in May, 2014. A total of 133 patients with documented paroxysmal AF were enrolled from 5 centers and randomized to PAR group or PVI group. Event ECG recorder and Holter monitoring were conductedduring the follow-up for all patients. Results: The average procedure time was 151±23 min in PAR group and 178±43 min in PVI group ( P <0.001). The average fluoroscopy time was 21±7 min in PAR group and 27±11 min in PVI group ( P= 0.002). AF triggering foci were eliminated in 59 patients (89.4%) in PAR group, whereas, only 4 patients (6.0%) in PVI group (P<0.001).At median 36 (37-35) months of follow-up after single ablation procedure, 43 of 66 patients in PAR group (65%) and 28 of 67 patients in PVI group (42%) had no recurrence of AF off antiarrhythmic drug (AAD) (P=0.007); and 47 of 66 patients in PAR group (71%) and 32 of 67 patients in PVI group (48%) had no recurrence of AF with AAD (P=0.006). At the last follow-up, the burden of AF was significantly lower in PAR group than in PVI group (0.9% ± 2.3% vs 4.9% ± 9.9%;90th percentile, 5.5% vs 19.6%; P=0.008). No major adverse event (death, stroke, PV stenosis) was observed in all the patients except one case of pericardial tamponade. Conclusions: PAR ablation is a simple, safe, and effective strategy for the treatment of paroxysmal AF with better long-term outcome than PVI. PAR ablation might exhibit the beneficial effect on AF management through multiple mechanisms. Registration: ChiCTR-TRC-11001191


2017 ◽  
Vol 227 ◽  
pp. 407-412 ◽  
Author(s):  
Masateru Takigawa ◽  
Atsushi Takahashi ◽  
Taishi Kuwahara ◽  
Kenji Okubo ◽  
Yoshihide Takahashi ◽  
...  

2018 ◽  
Vol 38 (2) ◽  
pp. 259-267 ◽  
Author(s):  
Shang-wei Huang ◽  
Qi Jin ◽  
Ning Zhang ◽  
Tian-you Ling ◽  
Wen-qi Pan ◽  
...  

2018 ◽  
Vol 107 (5) ◽  
pp. 430-436 ◽  
Author(s):  
Sonia Busch ◽  
Mathias Forkmann ◽  
Karl-Heinz Kuck ◽  
Thorsten Lewalter ◽  
Hüseyin Ince ◽  
...  

2020 ◽  
Vol 75 (4) ◽  
pp. 352-359
Author(s):  
Takafumi Oka ◽  
Koji Tanaka ◽  
Yuichi Ninomiya ◽  
Yuko Hirao ◽  
Nobuaki Tanaka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document